Premier Path Wealth Partners’s Boston Scientific BSX Stock Holding History

Premier Path Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Sell	5,044 -4,070	-45%	-$221K	0.02%	390
2026 Q1	$572K	Buy	9,114 +378	+4%	+$30.2K	0.07%	243
2025 Q4	$833K	Sell	8,736 -381	-4%	-$37.4K	0.11%	178
2025 Q3	$890K	Buy	9,117 +344	+4%	+$35.6K	0.11%	187
2025 Q2	$942K	Buy	8,773 +73	+0.8%	+$7.39K	0.13%	177
2025 Q1	$878K	Buy	8,700 +9	+0.1%	+$906	0.14%	175
2024 Q4	$776K	Buy	8,691 +6	+0.1%	+$528	0.12%	180
2024 Q3	$728K	Sell	8,685 -34	-0.4%	-$2.68K	0.11%	185
2024 Q2	$671K	Buy	8,719 +6	+0.1%	+$439	0.11%	183
2024 Q1	$597K	Sell	8,713 -485	-5%	-$31.2K	0.11%	179
2023 Q4	$514K	Buy	+9,198	New	+$491K	0.11%	186

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Premier Path Wealth Partners's BSX Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its Boston Scientific (BSX) stake by 45% in Q2 2026, selling an estimated $221K and leaving 5,044 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #390.

Premier Path Wealth Partners first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $942K in Q2 2025. 464 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Premier Path Wealth Partners held 5,044 shares of Boston Scientific worth $215K as of Q2 2026.
Premier Path Wealth Partners sold 4,070 Boston Scientific shares in Q2 2026, an estimated $221K.
Boston Scientific made up 0.02% of Premier Path Wealth Partners's portfolio in Q2 2026, its #390 holding.
Premier Path Wealth Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Premier Path Wealth Partners's Boston Scientific position peaked at $942K in Q2 2025.
464 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.